Quaternary indazole glucocorticoid receptor antagonists
US-2025214971-A1 · Jul 3, 2025 · US
This page is not indexed by search engines while we improve data quality.
Mills Mark patents
Mills Mark is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mills Mark |
| Total patents | 18 |
| First publication | Jun 17, 2021 |
| Latest publication | Jul 3, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Bicyclic indazole glucocorticoid receptor antagonists
US-2025115583-A1 · Apr 10, 2025 · US
Piperazine indazole glucocorticoid receptor antagonists
US-2025092023-A1 · Mar 20, 2025 · US
Thiazolo[5,4-b]pyridine malt-1 inhibitors
US-2025084099-A1 · Mar 13, 2025 · US
Oxexin 1 receptor antagonists
US-12240825-B2 · Mar 4, 2025 · US
Quaternary indazole glucocorticoid receptor antagonists
US-12180186-B2 · Dec 31, 2024 · US
Bicyclic indazole glucocorticoid receptor antagonists
US-12098141-B2 · Sep 24, 2024 · US
Piperazine indazole glucocorticoid receptor antagonists
US-12098144-B2 · Sep 24, 2024 · US
Thiazolo[5,4-b]pyridine MALT-1 inhibitors
US-11993613-B2 · May 28, 2024 · US
Quaternary indazole glucocorticoid receptor antagonists
US-2024150320-A1 · May 9, 2024 · US
Recent patents
Latest publications not already listed above.
Quaternary indazole glucocorticoid receptor antagonists
US-11787780-B2 · Oct 17, 2023 · US
Thiazolo[5,4-b]pyridine malt-1 inhibitors
US-2023312601-A1 · Oct 5, 2023 · US
Bicyclic indazole glucocorticoid receptor antagonists
US-2023242514-A1 · Aug 3, 2023 · US
Piperazine indazole glucocorticoid receptor antagonists
US-2023192666-A1 · Jun 22, 2023 · US
Quaternary indazole glucocorticoid receptor antagonists
US-2023032612-A1 · Feb 2, 2023 · US
Oxexin 1 receptor antagonists
US-2022098165-A1 · Mar 31, 2022 · US
Orexin 1 receptor antagonists
US-2022041573-A1 · Feb 10, 2022 · US
Ox1 antagonists
US-2021179578-A1 · Jun 17, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Corcept Therapeutics Inc | 11 |
| Heptares Therapeutics Ltd | 4 |
| Abbvie Inc | 3 |
| Nxera Pharma Uk Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/14 | 13 |
| C07D401/04 | 12 |
| C07D413/14 | 11 |
| C07D403/14 | 11 |
| C07D403/04 | 11 |